BCAX

Bicara Therapeutics
BCAX

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$22
30% upside
High target

4 analyst ratings

positive
2  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wedbush
Wedbush
David Nierengarten
67% 1-yr BCAX win rate
13 Jan ‘26 5 days ago
BTIG
BTIG
Jeet Mukherjee
0% 1-yr BCAX win rate
8 Jan ‘26 10 days ago
Mizuho
Mizuho
Joseph Catanzaro
18 Dec ‘25 1 month ago
Wells Fargo
Wells Fargo
Eva Fortea Verdejo
0% 1-yr BCAX win rate
11 Nov ‘25 2 months ago